IPN, Delhi, India. Open 10-6pm

+91 9891296838 / 9811747774

Lecanemab-IRMB Injection

lecanemab-irmb injection,
for intravenous use Initial U.S. Approval: 2023

Lecanemab-irmb injection is “used to treat Alzheimer’s disease“. LEQEMBI for injection is aprescription medicine”. It is available in “form and strength” Tablets: 10 mg, 50 mg, 100 mg. LEQEMBI  Injection can be obtained in India upon request.
To inquire about the LEQEMBI (lecanemab-irmb) injection“ offer price in India”, “shipping process”, and the “estimated time of availability in India”, please get in touch at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj). with the IPN Delhi healthcare team for further discussion.”

Facts about your medicine

• 500 mg/5 mL (100 mg/mL) solution in a single-dose vial.
• 200 mg/2 mL (100 mg/mL) solution in a single-dose vial.
Alzheimer’s disease
MANUFACTURER: Eisai Europe Ltd
USAGE: Intravenous
MEDICINE APPROVED BY: Food and Drug Administration (FDA)

Extra Information:

Contact Info

Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398



Query For Lecanemab-IRMB Injection

Know about product usage and updates

Lecanemab-irmb is a recombinant humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble and insoluble forms of amyloid beta, and is expressed in a Chinese hamster ovary cell line. Lecanemab-irmb has an approximate molecular weight of 150 kDa.

lecanemab-irmb injection is a preservative-free, sterile, clear to opalescent and colorless to pale yellow solution for intravenous use by infusion after dilution. LEQEMBI is supplied in single-dose vials available in concentrations of 500 mg/5 mL (100 mg/mL) or 200 mg/2 mL (100 mg/mL). Each mL of solution contains 100 mg of lecanemab-irmb and arginine hydrochloride (42.13 mg), histidine (0.18 mg), histidine hydrochloride monohydrate (4.99 mg), polysorbate 80 (0.50 mg), and Water for Injection at an approximate pH of 5.0.

Who is the supplier of Specialty drug in India?

Indian Pharma Network (IPN) Legitimate consultant and facilitator for Specialty drugs in India. IPN, Delhi can assist you in connecting with prospective distributors, wholesalers, suppliers, and dealers of LEQEMBI (lecanemab-irmb) injection. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

LEQEMBI (lecanemab-irmb) injection, for intravenous use Initial U.S. Approval: 2023

Related posts for product review usage

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa

Indian Pharma Network
60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398